Cell-Free Nucleic Acids

The deficits of mammography and the potential of noninvasive diagnostic testing using circulating miRNA profiles are presented in our first review article. Exosomes are important in the transfer of genetic information. The current knowledge on exosome-associated DNAs and on vesicle-associated DNAs a...

Full description

Saved in:
Bibliographic Details
:
Year of Publication:2020
Language:English
Physical Description:1 electronic resource (248 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 05836nam-a2201141z--4500
001 993548368204498
005 20231214133443.0
006 m o d
007 cr|mn|---annan
008 202102s2020 xx |||||o ||| 0|eng d
020 |a 3-03928-075-9 
035 |a (CKB)4100000010163790 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/42861 
035 |a (EXLCZ)994100000010163790 
041 0 |a eng 
100 1 |a Nagy, Bálint  |4 auth 
245 1 0 |a Cell-Free Nucleic Acids 
260 |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2020 
300 |a 1 electronic resource (248 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a The deficits of mammography and the potential of noninvasive diagnostic testing using circulating miRNA profiles are presented in our first review article. Exosomes are important in the transfer of genetic information. The current knowledge on exosome-associated DNAs and on vesicle-associated DNAs and their role in pregnancy-related complications is presented in the next article. The major obstacle is the lack of a standardized technique for the isolation and measurement of exosomes. One review has summarized the latest results on cell-free nucleic acids in inflammatory bowel disease (IBD). Despite the extensive research, the etiology and exact pathogenesis are still unclear, although similarity to the cell-free ribonucleic acids (cfRNAs) observed in other autoimmune diseases seems to be relevant in IBD. Liquid biopsy is a useful tool for the differentiation of leiomyomas and sarcomas in the corpus uteri. One manuscript has collected the most important knowledge of mesenchymal uterine tumors and shows the benefits of noninvasive sampling. Microchimerism has also recently become a hot topic. It is discussed in the context of various forms of transplantation and transplantation-related advanced therapies, the available cell-free nucleic acid (cfNA) markers, and the detection platforms that have been introduced. Ovarian cancer is one of the leading serious malignancies among women, with a high incidence of mortality; the introduction of new noninvasive diagnostic markers could help in its early detection and treatment monitoring. Epigenetic regulation is very important during the development of diseases and drug resistance. Methylation changes are important signs during ovarian cancer development, and it seems that the CDH1 gene is a potential candidate for being a noninvasive biomarker in the diagnosis of ovarian cancer. Preeclampsia is a mysterious disease—despite intensive research, the exact details of its development are unknown. It seems that cell-free nucleic acids could serve as biomarkers for the early detection of this disease. Three research papers deal with the prenatal application of cfDNA. Copy number variants (CNVs) are important subjects for the study of human genome variations, as CNVs can contribute to population diversity and human genetic diseases. These are useful in NIPT as a source of population specific data. The reliability of NIPT depends on the accurate estimation of fetal fraction. Improvement in the success rate of in vitro fertilization (IVF) and embryo transfer (ET) is an important goal. The measurement of embryo-specific small noncoding RNAs in culture media could improve the efficiency of ET. 
546 |a English 
653 |a screening 
653 |a single nucleotide polymorphism 
653 |a predictive and preventive approach 
653 |a PTEN 
653 |a cell-free DNAs 
653 |a fetal fraction 
653 |a gestational hypertension 
653 |a RASSF1 
653 |a CDH1 
653 |a RT-PCR 
653 |a cfDNA 
653 |a statistical models 
653 |a hematopoietic stem cell transplantation 
653 |a NanoString 
653 |a solid organ transplantation 
653 |a copy number variants 
653 |a sarcomas 
653 |a liquid biopsy 
653 |a obesity 
653 |a fetal DNA 
653 |a neutrophil extracellular traps 
653 |a mammography 
653 |a non-invasive prenatal testing 
653 |a ovarian cancer 
653 |a circulating miRNA 
653 |a pyrosequencing 
653 |a growth retardation 
653 |a preeclampsia 
653 |a gestational diabetes mellitus 
653 |a biomarker 
653 |a inflammatory bowel disease 
653 |a multi-level diagnostics 
653 |a PAX1 
653 |a population study 
653 |a nuclease activity 
653 |a NETosis 
653 |a omics 
653 |a piRNA 
653 |a cell-free DNA 
653 |a prediction 
653 |a leiomyosarcomas 
653 |a network analysis 
653 |a NGS 
653 |a statistical methods 
653 |a circulating nucleic acids 
653 |a deletion/insertion polymorphism 
653 |a gender differences 
653 |a leiomyomas 
653 |a fetal growth restriction 
653 |a blood plasma 
653 |a exosomes 
653 |a miRNA 
653 |a pregnancy-related complications 
653 |a NIPT 
653 |a genetic marker 
653 |a cell-free nucleic acids 
653 |a extracellular vesicles 
653 |a expression 
653 |a next generation sequencing 
653 |a breast cancer 
653 |a individualized patient profile 
653 |a circulating tumor cells 
653 |a maternal serum screening 
653 |a personalized medicine 
653 |a embryo culture medium 
653 |a C19MC microRNA 
653 |a DNA 
653 |a cell-free RNAs 
653 |a z-score 
653 |a fetal cells 
653 |a microchimerism 
653 |a aging 
653 |a plasma 
776 |z 3-03928-074-0 
906 |a BOOK 
ADM |b 2023-12-15 05:54:29 Europe/Vienna  |f system  |c marc21  |a 2020-02-22 21:58:18 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338793020004498&Force_direct=true  |Z 5338793020004498  |b Available  |8 5338793020004498